razoxane has been researched along with transferrin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasinoff, BB; Kala, SV | 1 |
| Huang, X; Katz, SD; Zhang, Q; Zheng, H | 1 |
1 trial(s) available for razoxane and transferrin
| Article | Year |
|---|---|
Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects.
Topics: Adult; Anemia, Iron-Deficiency; Brachial Artery; Cardiovascular Diseases; Chelating Agents; Double-Blind Method; Endothelium, Vascular; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Homocysteine; Humans; Iron; Male; Methionine; Nitroglycerin; Oxidative Stress; Razoxane; Regional Blood Flow; Risk Factors; Transferrin; Tyrosine; Vasodilation | 2006 |
1 other study(ies) available for razoxane and transferrin
| Article | Year |
|---|---|
The removal of metal ions from transferrin, ferritin and ceruloplasmin by the cardioprotective agent ICRF-187 [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane] and its hydrolysis product ADR-925.
Topics: Ceruloplasmin; Chelating Agents; Copper; Dialysis; Ferritins; Hydrogen-Ion Concentration; Iron; Metals; Razoxane; Spectrophotometry, Ultraviolet; Transferrin | 1993 |